Prothena Corporation (NASDAQ:PRTA) is a clinical-stage neuroscience company that discovers and develops novel therapies for ...

In the span of just 52 weeks, Target (NYSE: TGT) has traded as low as $87.35 per share and as high as $167.40 per share.

In other words, Target stock is "cheap" when compared to the valuation of the S&P 500, meaning it's merely less expensive ...

It was a hot afternoon in Port Moresby. Kepa Wagi sat under a mango tree near his house in Hohola, wiping sweat from his forehead.

On May 22, Citi analyst Paul Lejuez lowered the firm’s price target on Target Corp. (NYSE: TGT) to $94 from $97, keeping a ...

Many investors were eager to see how retail giant Target's (NYSE: TGT) latest quarter would look, and, unfortunately, it wasn ...

Wells Fargo lowered its price target on Target Corp. (NYSE:TGT) to $115 from $135 but kept an Overweight rating on the shares ...

One of the largest and most important dairy farms in south-eastern Mexico, covering 1562ha in the state of Campeche, is on ...

Bernstein kept an Underperform rating on Target Corp. (NYSE:TGT) and lowered the associated price target to $80 from $82. The ...

The disappointing performance and the lack of clarity around tariffs and the overall macroeconomic picture led Target to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.